Slingshot Insights | Clvs Overview

CLVS Overview

Upcoming Projects (CLVS)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (CLVS)

A Second Look: Examining the recent TRITON3 Phase 3 Clinical Data of Rubraca (rucaparib) from Clovis Oncology for the Treatment of Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations.
Ticker: CLVS
Executed On: Nov 22, 2022 at 06:30 PM EST
Examining the recent TRITON3 Phase 3 Clinical Data of Rubraca (rucaparib) from Clovis Oncology for the Treatment of Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations.
Ticker: CLVS
Executed On: Oct 28, 2022 at 10:15 AM EDT
A second look at the P1 data presented at ESMO for ubamatamab, a CD3-targeting bispecific antibody under investigation for recurrent ovarian cancer
Tickers: REGN, AZN, CLVS, IMGN, GSK, RHHBY
Executed On: Sep 29, 2022 at 05:15 PM EDT

Upcoming & Overdue Catalysts (CLVS)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (CLVS)

Don’t see a strategic initiative related to the company you care about? Create your own!